Company: NCEL
Filing Date: 2025-11-06
Form Type: POS AM
Source: 0001213900-25-106799
Chunk: 32

Company: NewcelX Ltd.
Filing Date: 2025-11-06
Form: POS AM
Chunk 32
---
 additional funding and increasing revenues to address operational deficits. Interest rates play a critical role in these estimates, as they influence borrowing costs and the valuation of financial assets and liabilities. The accounting for expected R&D grants involves assumptions about the timing and amount of receipts, which can be uncertain due to regulatory processes and associated conditions. 18 Quantitative and Qualitative Disclosure About Market Risk Kadimastem is exposed to market risks in the ordinary course of Kadimastem’s business. Market risk represents the risk of loss that may impact Kadimastem’s financial position, results of operations or cash flows due to adverse changes in financial market prices and rates, including interest rates and foreign exchange rates, of financial instruments. Interest Rate Risk Following the date of this prospectus supplement, Kadimastem does not anticipate undertaking any significant long -termborrowings. At present, Kadimastem’s investments consist primarily of cash and cash equivalents and financial assets at fair value. Following the date of this proxy statement/prospectus, Kadimastem may invest in investment -grademarketable securities with maturities of up to three years, including commercial paper, money market funds, and government/non -governmentdebt securities. The primary objective of Kadimastem’s investment activities is to preserve principal while maximizing the income that it receives from its investments without significantly increasing risk and loss. Kadimastem’s investments are exposed to market risk due to fluctuation in interest rates, which may affect its interest income and the fair market value of its investments, if any. Kadimastem manages this exposure by performing ongoing evaluations of its investments. Due to the short -termmaturities, if any, of its investments to date, their carrying value has always approximated their fair value. If Kadimastem decides to invest in investments other than cash and cash equivalents, it will be its policy to hold such investments to maturity in order to limit its exposure to interest rate fluctuations. 19 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS The following unaudited pro forma condensed combined financial information was prepared in accordance with Article 11 of Regulation S -X under the Securities Act of 1933, as amended. The following information and all other information contained in the Unaudited Pro Forma Condensed Combined Financial Statements contained elsewhere in this Report on Form 6 -K reflects a notice of a reverse split with the commercial registry of the Canton of Zurich, Switzerland, on September 27, 202